Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Melatonin controls experimental autoimmune encephalomyelitis by altering the T effector/regulatory balance.
Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases.
[Immunotherapy and infectious issues in multiple sclerosis : Self-injectable and oral drugs for immunotherapy].
Safety, Tolerability, and Efficacy of Oral Therapies for Relapsing-Remitting Multiple Sclerosis.
Loss of astrocytic leptin signaling worsens experimental autoimmune encephalomyelitis.
[Low back pain: atypical presentation of multiple sclerosis.]
Serum nicotinamide adenine dinucleotide levels through disease course in multiple sclerosis.
Lower Serum Levels of Th2-Related Chemokine CCL22 in Women Patients with Multiple Sclerosis: A Comparison Between Patients and Healthy Women.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
The coexistence of well- and ill-being in persons with multiple sclerosis, their caregivers and health professionals.
Patient education programme on immunotherapy in multiple sclerosis (PEPIMS): A controlled rater-blinded study.
Concise review: Stem cell trials using companion animal disease models.
Identifying Patient-Specific Epstein-Barr Nuclear Antigen-1 Genetic Variation and Potential Autoreactive Targets Relevant to Multiple Sclerosis Pathogenesis.
Deletion of CTLA-4 on regulatory T cells during adulthood leads to resistance to autoimmunity.
Pregnancy outcomes in aquaporin-4-positive neuromyelitis optica spectrum disorder.
Muscle Expression of SOD1(G93A) Modulates microRNA and mRNA Transcription Pattern Associated with the Myelination Process in the Spinal Cord of Transgenic Mice.
Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
Microwave & magnetic (M(2) ) proteomics of the EAE animal model of multiple sclerosis.
Ultrasonography in distinguishing optic neuritis from nonarteritic anterior ischemic optic neuropathy.
The fine balance of chemokines during disease: trafficking, inflammation, and homeostasis.
Evaluation of Retinoids for Induction of the Redundant Gene ABCD2 as an Alternative Treatment Option in X-Linked Adrenoleukodystrophy.
Testicular hypofunction and multiple sclerosis: Cause or consequence? Author's reply.
Item response theory-based measure of global disability in multiple sclerosis derived from the Performance Scales and related items.
Earlier and more frequent diagnosis of multiple sclerosis using the McDonald criteria.
The role of the community nurse in care provision for people with multiple sclerosis.
Pages
« first
‹ previous
…
448
449
450
451
452
453
454
455
456
…
next ›
last »